AbbVie Header AbbVie Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Cohance Lifesciences.

    Client Virtual Booth

    COHANCE LIFESCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    Key Products KEY PRODUCTS

    • Exatecan

    • Irinotecan Hydrochloride

    • Lenalidomide

    • Methotrexate

    • S-trione

    • SN38

    • Topotecan Hydrochloride

    INTERMEDIATES

    SERVICES

    Key Products KEY SERVICES

    • Antibody Drug Conjugates (ADCs)

    • Custom Development & Manufacturing for ADCs

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cohance Lifesciences
    Cohance Lifesciences
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Panmaktha Plot, 1, Hitech City Rd, opp. IKEA, Hyderabad, Telangana 500081
    Telephone
    Telephone
    +91 4044758595
    Client Email
    Email
    enquiries@cohance.com
    Client Website
    Website
    https://cohance.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cohance-lifesciences/
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Avra Laboratories Gets Regulatory Approval for Covid-19 Drug Favipiravir

    Details:

    Ciplenza (favipiravir-generic) is a RNA-directed RNA polymerase inhibitor, small molecule, which is indicated for the treatment of patients with Covid-19 infection.


    Lead Product(s): Favipiravir

    Therapeutic Area: Infections and Infectious Diseases Product Name: Ciplenza

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 27, 2020

    Cohance

    CPhI Worldwide, Milan

    Booth #4B1

    envelop Contact Supplier

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Cohance Lifesciences

    CPhI Worldwide, Milan

    Booth #4B1

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search